The prevalence and clinical course of HIV-associated pulmonary cryptococcosis in Uganda

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue 3, 2010, Pages 269-274

  Deok Jong Yoo, Samuel ^a   Worodria, William ^a   Davis, J L ^a,b   Cattamanchi, Adithya ^a,b   Den Boon, Saskia ^a   Kyeyune, Rachel ^a   Kisembo, Harriet ^a   Huang, Laurence ^a,b,c  

^a MAKERERE UNIVERSITY   (Uganda)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

bronchoscopy; HIV AIDS; pulmonary cryptococcosis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; FLUCONAZOLE;

ADULT; ARTICLE; BRONCHOSCOPY; CD4 LYMPHOCYTE COUNT; CRYPTOCOCCUS NEOFORMANS; DISEASE COURSE; FEMALE; FOLLOW UP; FUNGUS CULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PULMONARY CRYPTOCOCCOSIS; THRUSH; UGANDA;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; HIV INFECTIONS; HUMANS; LUNG DISEASES, FUNGAL; MALE; PREVALENCE; TUBERCULOSIS, PULMONARY; UGANDA;

EID: 77954052027     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181ce6b19     Document Type: Article

References (32)

1. Kobayashi G. Fungi. In: Davis BD, ed. Microbiology. Philadelphia, PA: J.B. Lippincott Company; 1980:751.
2. Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23:525-530.
3. Powderly WG, Finkelstein D, Feinberg J, et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med. 1995; 332:700-705.
4. French N, Gray K, Watera C, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS. 2002;16:1031-1038.
5. Churchyard GJ, Kleinschmidt I, Corbett EL, et al. Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2000;4:705-712.
6. Kent PT, Kubica G. Public Health Mycobacteriology. A Guide for the Level III Laboratory. Atlanta, GA: Centers for Disease Control; 1985.
7. Koneman EW, Robert G. Mycotic disease. In: Henry JB, ed. Clinical Diagnosis and Management by Laboratory Methods. Philadelphia, PA: Saunders; 1984:1186.
8. Cattamanchi A, Davis JL, Worodria W, et al. Poor performance of universal sample processing method for diagnosis of pulmonary tuberculosis by smear microscopy and culture in Uganda. J Clin Microbiol. 2008;46:3325-3329.
9. Daley CL, Mugusi F, Chen LL, et al. Pulmonary complications of HIV infection in Dar-es-Salaam, Tanzania. Role of bronchoscopy and bronchoalveolar lavage. Am J Respir Crit Care Med. 1996;154:105-110.
10. Grant AD, Djomand G, Smets P, et al. Profound immunosuppression across the spectrum of opportunistic disease among hospitalised HIV-infected adults in Abidjan, Cote d'Ivoire. AIDS. 1997;11:1357-1364.
11. Batungwanayo J, Taelman H, Lucas S, et al. Pulmonary diseases associated with the human immunodeficiency virus in Kigali, Rwanda. A fiberoptic bronchoscopic study of 111 cases of undetermined etiology. Am J Respir Crit Care Med. 1994;149:1591-1596.
12. Mirza SA, Phelan M, Rimland D, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis. 2003;36:789-794.
13. Wong ML, Back P, Candy G, et al. Cryptococcal pneumonia in African miners at autopsy. Int J Tuberc Lung Dis. 2007;11:528-533.
14. Wasser L, Talavera W. Pulmonary cryptococcosis in AIDS. Chest. 1987; 92:692-695.
15. Clark RA, Greer DL, Valanis GT, et al. Cryptococcus neoformans pulmonary infection in HIV-1-infected patients. J Acquir Immune Defic Syndr. 1990;3:480-484.
16. Meyohas MC, Roux P, Bollens D, et al. Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis. 1995;21:628-633.
17. DeLorenzo LJ, Huang C, Maguire GP, et al. Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS. Chest. 1987; 91:323-327.
18. Yoo DJ, Lee K, Munderi P, et al. Clinical and bronchoscopic findings in Ugandans with pulmonary Kaposi's sarcoma. Kor J Intern Med. 2005;20: 290-294.
19. Zolopa A, Anderson J, Komarow L, et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One. 2009;4: e5575.
20. Kambugu A, Meya DB, Rhein J, et al. Outcomes of Cryptococcal meningitis in Uganda before and after the availability of HAART. Clin Infect Dis. 2008;46:1694-1701.
21. Liechty C, Solberg, P, Were W, et al. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health. 2007;12:929-935.
22. Meya D, Castelnuovo B, Kambugu A, et al. Cost effectiveness of serum cryptococcal antigen (CRAG) screening to prevent death in HIV-infected persons with CD4, 100/mL in sub-Saharan Africa. TUAD104. Abstract. Presented at: 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention; 2009; Cape town, South Africa.
23. Swinne D, Deppner M, Maniratunga S, et al. AIDS-associated cryptococcosis in Bujumbura, Burundi: an epidemiological study. Med Mycol. 1991;29:25-30.
24. Swinne D, Taelman H, Batungwanayo J, et al. Ecology of Cryptococcus neoformans in central Africa. Med Trop (Mars). 1994;54:53-55.
25. Kidd SE, Chow Y, Mak S, et al. Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States. Appl Environ Microbiol. 2007;73:1433-1443.
26. Diamond RD. Cryptococcus neoformans. In: Mandell GL, ed. Principles and Practice of Infectious Diseases. Philadelphia, PA; Churchill Livingstone; 2000:2707-2718.
27. Feldman C. Cryptococcal pneumonia. Clin Pulm Med. 2003;10:67-71.
28. Cox GM, Perfect J. Cryptococcal pneumonia. Uptodate. 2008.
29. Saag MS, Graybill R, Larsen RA, et al. Practice guideline for the management of Cryptococcal disease. Clin Infect Dis. 2000;30:710-718.
30. Sukroongreung S, Eampokalap B, Tansuphaswadiku S, et al. Recovery of Cryptococcus neoformans from the nasopharynx of AIDS patients. Mycopathologia. 1999;143:131-134.
31. Aberg JA, Mundy LM, Powderly WG. Pulmonary Cryptococcosis in patients without HIV infection. Chest. 1999;115:734-740.
32. Aberg JA. Pulmonary Cryptococcosis in normal hosts. Chest. 2003;124: 2049-2051.